One-year efficacy of adjunctive use of Ripasudil, a rho-kinase inhibitor, in patients with glaucoma inadequately controlled with maximum medical therapy
Crossref DOI link: https://doi.org/10.1007/s00417-017-3727-5
Published Online: 2017-07-15
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Inazaki, Hiroshi
Kobayashi, Satoshi
Anzai, Yoko
Satoh, Hisayoshi
Sato, Shimpei
Inoue, Maiko
Yamane, Shin
Kadonosono, Kazuaki
License valid from 2017-07-15